154 related articles for article (PubMed ID: 3918312)
1. Salicylic acid blocks indomethacin-induced cyclooxygenase inhibition and lesion formation in rat gastric mucosa.
Ligumsky M; Guth PH; Elashoff J; Kauffman GL; Hansen D; Paulsen G
Proc Soc Exp Biol Med; 1985 Feb; 178(2):250-3. PubMed ID: 3918312
[TBL] [Abstract][Full Text] [Related]
2. Salicylic acid blocks indomethacin- and aspirin-induced cyclo-oxygenase inhibition in rat gastric mucosa.
Ligumsky M; Hansen DG; Kauffman GL
Gastroenterology; 1982 Nov; 83(5):1043-6. PubMed ID: 6811367
[TBL] [Abstract][Full Text] [Related]
3. Protection by mild irritants against indomethacin-induced gastric mucosal damage in the rat: role of prostaglandin synthesis.
Ligumsky M; Sestieri M; Karmeli F; Rachmilewitz D
Isr J Med Sci; 1986 Nov; 22(11):807-11. PubMed ID: 3098701
[TBL] [Abstract][Full Text] [Related]
4. Functional mechanism underlying COX-2 expression following administration of indomethacin in rat stomachs: importance of gastric hypermotility.
Takeuchi K; Tanaka A; Hayashi Y; Kubo Y
Dig Dis Sci; 2004 Feb; 49(2):180-7. PubMed ID: 15104355
[TBL] [Abstract][Full Text] [Related]
5. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach.
Ukawa H; Yamakuni H; Kato S; Takeuchi K
Dig Dis Sci; 1998 Sep; 43(9):2003-11. PubMed ID: 9753266
[TBL] [Abstract][Full Text] [Related]
6. Roles of endogenous prostaglandins and cyclooxygenase izoenzymes in mucosal defense of inflamed rat stomach.
Takeeda M; Hayashi Y; Yamato M; Murakami M; Takeuchi K
J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):193-205. PubMed ID: 15082878
[TBL] [Abstract][Full Text] [Related]
7. Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis.
Kato S; Ogawa Y; Kanatsu K; Okayama M; Watanabe T; Arakawa T; Takeuchi K
J Pharmacol Exp Ther; 2002 Nov; 303(2):503-9. PubMed ID: 12388629
[TBL] [Abstract][Full Text] [Related]
8. Cyclo-oxygenase isozymes in mucosal ulcergenic and functional responses following barrier disruption in rat stomachs.
Hirata T; Ukawa H; Yamakuni H; Kato S; Takeuchi K
Br J Pharmacol; 1997 Oct; 122(3):447-54. PubMed ID: 9351500
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of COX-2 by inhibition of COX-1 in the rat: a key to NSAID-induced gastric injury.
Tanaka A; Araki H; Hase S; Komoike Y; Takeuchi K
Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():90-101. PubMed ID: 11966529
[TBL] [Abstract][Full Text] [Related]
10. Different modes of inhibition of rat gastric mucosal 6-keto-PGF1 alpha production by indomethacin, aspirin and aminopyrine.
Nishikawa T; Tomori Y; Yamashita S; Shimizu S
Jpn J Pharmacol; 1989 Apr; 49(4):483-9. PubMed ID: 2498559
[TBL] [Abstract][Full Text] [Related]
11. Gastric effects of the selective cyclooxygenase-2 inhibitor, celecoxib, in the rat.
Coppelli G; Guaita E; Spaggiari S; Coruzzi G
Dig Liver Dis; 2004 Apr; 36(4):265-70. PubMed ID: 15115339
[TBL] [Abstract][Full Text] [Related]
12. Role of cyclooxygenase-2 in gastric mucosal defense.
Peskar BM; Maricic N; Gretzera B; Schuligoi R; Schmassmann A
Life Sci; 2001 Nov; 69(25-26):2993-3003. PubMed ID: 11758826
[TBL] [Abstract][Full Text] [Related]
13. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
[TBL] [Abstract][Full Text] [Related]
15. Effects of non-steroidal anti-inflammatory drugs on rat gastric mucosal leukotriene C4 and prostanoid release: relation to ethanol-induced injury.
Peskar BM; Hoppe U; Lange K; Peskar BA
Br J Pharmacol; 1988 Apr; 93(4):937-43. PubMed ID: 3390662
[TBL] [Abstract][Full Text] [Related]
16. A selective cyclo-oxygenase-2 inhibitor, NS-398, may improve portal hypertension without inducing gastric mucosal injury.
Tsugawa K; Hashizume M; Migou S; Kishihara F; Kawanaka H; Tomikawa M; Sugimachi K
J Gastroenterol Hepatol; 1999 Jul; 14(7):642-51. PubMed ID: 10440208
[TBL] [Abstract][Full Text] [Related]
17. Gastric cytoprotection by sodium salicylate.
Robert A
Prostaglandins; 1981; 21 Suppl():139-46. PubMed ID: 7302258
[TBL] [Abstract][Full Text] [Related]
18. The anti-inflammatory effect of FR188582, a highly selective inhibitor of cyclooxygenase-2, with an ulcerogenic sparing effect in rats.
Ochi T; Yamane-Sugiyama A; Ohkubo Y; Sakane K; Tanaka H
Jpn J Pharmacol; 2001 Feb; 85(2):175-82. PubMed ID: 11286400
[TBL] [Abstract][Full Text] [Related]
19. Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge.
Gretzer B; Maricic N; Respondek M; Schuligoi R; Peskar BM
Br J Pharmacol; 2001 Apr; 132(7):1565-73. PubMed ID: 11264251
[TBL] [Abstract][Full Text] [Related]
20. Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Drozdowicz D; KwiecieĊ S; Pajdo R; Ptak A; Pawlik M; Hahn E
Dig Liver Dis; 2000 Oct; 32(7):583-94. PubMed ID: 11142556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
